z-logo
Premium
[P2–130]: AR‐A014418, A GSK‐3β INHIBITOR, ATTENUATES ALZHEIMER'S‐ LIKE PATHOLOGY IN HIGH FAT DIET‐INDUCED COGNITIVE DEFICIT IN MICE
Author(s) -
Sharma Sorabh,
Taliyan Rajeev
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.780
Subject(s) - endocrinology , medicine , gsk 3 , morris water navigation task , insulin resistance , glycogen synthase , tau protein , hippocampal formation , hyperphosphorylation , cognitive decline , glial fibrillary acidic protein , hippocampus , chemistry , alzheimer's disease , insulin , kinase , dementia , disease , biochemistry , immunohistochemistry
the underlying mechanisms involved. Results:Our ChIP analysis and luciferase reporter assays show that palmitate-induced SREBP1 activation directly regulates BACE1 expression at the transcriptional level. Knocking-down or ectopic expression of the dominant negative SREBP1 mutant significantly mitigated the palmitate-induced BACE1 expression and subsequent Ab genesis. Conclusions: Our study elucidates a novel signaling pathway and SREBP1 as a unique downstream effector of palmitate-induced up-regulation in BACE1 expression and subsequent Ab genesis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom